(Sharecast News) - Physiomics said on Friday that its newly-appointed board had started a wide-ranging review of the business focused on operational optimisation, commercial execution and shareholder value creation.
The AIM-traded mathematical modelling, data science and biostatistics company said the board believed Physiomics had "underappreciated strengths", including an established scientific platform,...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE